Acute and Chronic Therapeutic Impact of a Vasopressin 2 Antagonist (Tolvaptan) in Congestive Heart Failure (ACTIV in CHF): A multicenter, randomized trial in patients hospitalized with worsening heart failure

Journal Article

Duke Authors

Cited Authors

  • Gheorghiade, M; O'Connor, C; Adams, K; Gattis, W; Barbagelata, NA; Elkayam, U; McGrew, F; Ghai, J; Benza, R; Klaphoiz, M; Orlandi, C; ACTIV Trial Investigators,

Published Date

  • 2004

Published In

  • Jama

Volume / Issue

  • 291 /

Start / End Page

  • 1961 - 1971